Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
about
What's next after metformin? focus on sulphonylurea: add-on or combination therapySodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight.Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc AnalysisEffects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.
P2860
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@ast
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@en
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@nl
type
label
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@ast
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@en
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@nl
prefLabel
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@ast
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@en
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@nl
P2860
P356
P1476
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
@en
P2093
P2860
P304
P356
10.4103/2230-8210.139214
P407
P577
2014-09-01T00:00:00Z